asdf

Idiopathic pulmonary fibrosis (IPF) presents ongoing challenges across the patient journey, from timely diagnosis to long-term disease management. Nonspecific symptoms often delays appropriate imaging and referral, while issues related to antifibrotic tolerability and treatment discontinuation may further complicate care. Clinicians must also consider changes in physiologic measures, including DLco, alongside emerging understanding of pulmonary vascular involvement and evolving therapeutic approaches.

In this podcast, Dr. Kevin Flaherty shares expert perspectives and case-based insights on recognizing IPF earlier, optimizing antifibrotic therapy, proactively addressing adverse events, and interpreting key diagnostic and prognostic indicators. Listen in to explore strategies that can help inform timely diagnosis, individualized treatment decisions, and ongoing care for patients living with IPF.

Launch/Release Date: September 14, 2026

Activity Expiration Date: August 31, 2027

FACULTY

Kevin Flaherty, MD

Director, Interstitial Lung Disease Program

University of Michigan Health

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Despite progress in disease identification and treatment strategies, PAH continues to carry considerable morbidity and mortality, highlighting the need for continued optimization of disease management.

Throughout this educational podcast, Dr. Vallerie McLaughlin highlights the latest advances in PAH presented at the International 2026 Conference in Orlando, FL.

Launch Date/Release Date: May 21 2026

Expiration Date: April 30, 2027

FACULTY

Vallerie McLaughlin, MD

Kim A. Eagle, MD Endowed Professor of Cardiovascular Medicine

University of Michigan Medical School

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

In this expert-led podcast, Dr. Nathan shares practical insights on recognizing early indicators of PH in the setting of ILD, interpreting key diagnostic findings, and applying effective risk stratification strategies. The discussion focuses on improving early detection and optimizing management to ultimately enhance outcomes for this high-risk patient population.

Launch Date/Release Date: May 7, 2026

Expiration Date: April 30, 2027

FACULTY

Steven Nathan, MD

Schar Chair

Medical Director, Advanced Lung Disease and Transplant Program

Inova Fairfax Hospital

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

New analyses show rising prevalence of progressive pulmonary fibrosis, persistent diagnostic delays, and continued gaps in antifibrotic use. Fresh data from major trials, including nerandomilast, inhaled treprostinil, admilparant, deupirfenidone, and nalbuphine ER for chronic cough, point to meaningful advances on the horizon. At the same time, patient-centered research highlights the need for clearer communication, coordinated care, and earlier intervention to improve daily functioning and long-term outcomes.

This CME activity brings all these findings together in one clear, concise program that helps clinicians keep pace with a rapidly changing field and deliver more effective, patient-focused care.

Launch/Release Date: December 9, 2025 Activity Expiration Date: November 30, 2026

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Chronic obstructive pulmonary disease (COPD) remains a major global health challenge, characterized by significant unmet needs in early diagnosis, personalized management, and coordinated multidisciplinary care. Many patients continue to receive suboptimal, non-guideline-aligned treatment, often leading to poorer outcomes, increased exacerbations, and diminished quality of life.

Join Dr. Bose and Dr. Han as they present key clinical findings in COPD Management.

Launch Date/Release Date: October 30, 2025

Expiration Date: September 30, 2026

FACULTY

Sonali Bose, MD

Associate Professor of Medicine

Associate Professor of Pediatrics

Icahn School of Medicine at Mount Sinai

Adjunct Professor of Medicine

Johns Hopkins University

MeiLan Han, MD

Professor of Medicine

Chief, Division of Pulmonary and Critical Care Medicine

University of Michigan

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Chronic obstructive pulmonary disease (COPD) remains a major global health challenge, characterized by significant unmet needs in early diagnosis, personalized management, and coordinated multidisciplinary care. Many patients continue to receive suboptimal, non-guideline-aligned treatment, often leading to poorer outcomes, increased exacerbations, and diminished quality of life.

Join Dr. Bose and Dr. Han as they present key clinical findings in COPD Management.

Launch Date/Release Date: October 30, 2025

Expiration Date: September 30, 2026

FACULTY

Sonali Bose, MD

Associate Professor of Medicine

Associate Professor of Pediatrics

Icahn School of Medicine at Mount Sinai

Adjunct Professor of Medicine

Johns Hopkins University

MeiLan Han, MD

Professor of Medicine

Chief, Division of Pulmonary and Critical Care Medicine

University of Michigan

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Chronic obstructive pulmonary disease (COPD) remains a major global health challenge, characterized by significant unmet needs in early diagnosis, personalized management, and coordinated multidisciplinary care. Many patients continue to receive suboptimal, non-guideline-aligned treatment, often leading to poorer outcomes, increased exacerbations, and diminished quality of life.

Join Dr. Bose and Dr. Han as they present key clinical findings in COPD Management.

Launch Date/Release Date: October 30, 2025

Expiration Date: September 30, 2026

FACULTY

Sonali Bose, MD

Associate Professor of Medicine

Associate Professor of Pediatrics

Icahn School of Medicine at Mount Sinai

Adjunct Professor of Medicine

Johns Hopkins University

MeiLan Han, MD

Professor of Medicine

Chief, Division of Pulmonary and Critical Care Medicine

University of Michigan

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Chronic obstructive pulmonary disease (COPD) remains a major global health challenge, characterized by significant unmet needs in early diagnosis, personalized management, and coordinated multidisciplinary care. Many patients continue to receive suboptimal, non-guideline-aligned treatment, often leading to poorer outcomes, increased exacerbations, and diminished quality of life.

Join Dr. Bose and Dr. Han as they present key clinical findings in COPD Management.

Launch Date/Release Date: October 30, 2025

Expiration Date: September 30, 2026

FACULTY

Sonali Bose, MD

Associate Professor of Medicine

Associate Professor of Pediatrics

Icahn School of Medicine at Mount Sinai

Adjunct Professor of Medicine

Johns Hopkins University

MeiLan Han, MD

Professor of Medicine

Chief, Division of Pulmonary and Critical Care Medicine

University of Michigan

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

In this 15-minute podcast, Dr. Steven Nathan reviews clinically significant presentations, posters, and abstracts presented in Chicago from October 19-22, 2025, that offer key insights for improving the diagnosis and management of interstitial lung disease (ILD).

Launch Date/Release Date: October 23, 2025

Expiration Date: September 30, 2026

FACULTY

Steven Nathan, MD

Medical Director, Advanced Lung Disease and Transplant Program

Inova Fairfax Hospital

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.